Drug therapy of oncourological diseases. Overview of the most important events in 2020-21
Автор: Solodkiy V.A., Pavlov A.Yu., Dzidzaria A.G., Rieger A.N., Gafanov R.A.
Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr
Рубрика: Обзоры, лекции, методические рекомендации
Статья в выпуске: 2 т.21, 2021 года.
Бесплатный доступ
Recent years have been marked by serious breakthroughs in the drug therapy of malignant neoplasms. Almost constantly, we receive the results of more and more successful studies that affect our clinical practice and the fate of patients. Achievements in oncourology have not been left aside and even in some areas are ahead of the curve in comparison with other localizations. Over the past 12 months, new data from clinical trials have been obtained, which will be presented in this article.
Renal cell carcinoma (RCC), non-clear cell renal cell carcinoma (nRCC), chemotherapy (CT), urothelial cancer (UR), adverse events (AE), metastatic castration-resistant prostate cancer (mCRPC)
Короткий адрес: https://sciup.org/149135681
IDR: 149135681
